Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Oxaliplatin and Gemcitabine in HNC
NCT00256295Phase 2Terminated
- Start
- Apr 2005
- Primary completion
- Feb 2008
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in head and neck squamous cell carcinoma (HNSCC). Started Apr 2005; status: terminated.
02
Drugs
oxaliplatin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00256295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00256295.